ValuEngine Lowers MetLife (MET) to Hold

ValuEngine downgraded shares of MetLife (NYSE:MET) from a buy rating to a hold rating in a research note published on Friday.

A number of other research firms have also recently issued reports on MET. Zacks Investment Research cut MetLife from a buy rating to a hold rating in a report on Monday, January 22nd. Wells Fargo set a $62.00 target price on MetLife and gave the stock a buy rating in a report on Thursday, December 14th. Deutsche Bank assumed coverage on MetLife in a report on Tuesday, January 2nd. They issued a hold rating and a $55.00 target price for the company. Goldman Sachs reiterated a buy rating on shares of MetLife in a report on Wednesday, January 31st. Finally, Keefe, Bruyette & Woods reiterated a buy rating and issued a $56.00 target price on shares of MetLife in a report on Friday, February 23rd. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $56.75.

How to Become a New Pot Stock Millionaire

MET opened at $45.27 on Friday. MetLife has a 52-week low of $43.38 and a 52-week high of $55.91. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.15. The firm has a market cap of $46,928.83, a P/E ratio of 10.06, a price-to-earnings-growth ratio of 0.74 and a beta of 1.24.

MetLife (NYSE:MET) last posted its quarterly earnings data on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.41). MetLife had a net margin of 5.69% and a return on equity of 8.59%. The business had revenue of $15.79 billion for the quarter, compared to analysts’ expectations of $15.89 billion. During the same quarter in the previous year, the firm earned $1.28 EPS. research analysts forecast that MetLife will post 4.91 earnings per share for the current fiscal year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. raised its position in shares of MetLife by 17.1% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 72,131 shares of the financial services provider’s stock worth $3,647,000 after acquiring an additional 10,513 shares in the last quarter. Wagner Wealth Management LLC bought a new position in shares of MetLife in the 4th quarter worth $126,000. Xact Kapitalforvaltning AB raised its position in shares of MetLife by 6.0% in the 4th quarter. Xact Kapitalforvaltning AB now owns 161,838 shares of the financial services provider’s stock worth $8,183,000 after acquiring an additional 9,128 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of MetLife by 30.3% in the 4th quarter. Envestnet Asset Management Inc. now owns 234,037 shares of the financial services provider’s stock worth $11,834,000 after acquiring an additional 54,367 shares in the last quarter. Finally, CNB Bank bought a new position in shares of MetLife in the 4th quarter worth $338,000. 77.69% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This story was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3342588/valuengine-lowers-metlife-met-to-hold.html.

MetLife Company Profile

MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Head-To-Head Analysis: PHH  & Orix
Head-To-Head Analysis: PHH & Orix
Critical Survey: HTG Molecular Diagnostics  versus Coherent
Critical Survey: HTG Molecular Diagnostics versus Coherent
BitDice  Tops One Day Trading Volume of $2,352.00
BitDice Tops One Day Trading Volume of $2,352.00
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect NII  Share Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect NII Share Price
Electroneum Tops 1-Day Trading Volume of $1.27 Million
Electroneum Tops 1-Day Trading Volume of $1.27 Million
Reviewing William Demant  and Its Peers
Reviewing William Demant and Its Peers


Leave a Reply

© 2006-2018 Ticker Report. Google+.